Rosacea, SIBO & the Gut–Skin Axis: Looking Beyond the Surface

Rosacea is a chronic inflammatory skin disorder that can include persistent facial redness, flushing, papules, pustules, burning, stinging and sensitivity. Topical medications, oral medications and other dermatologic treatments can be important, but some patients also have gastrointestinal symptoms that deserve attention rather than being treated as unrelated.

Functional dermatology asks what may be influencing the skin's biology from both the outside and the inside. In selected patients, that includes examining the gut–skin axis and conditions such as small intestinal bacterial overgrowth, or SIBO.

Why the gut and skin can be connected

The gastrointestinal tract and skin are both barrier organs with active immune systems. Microbial metabolites, inflammatory signaling, nutrient status and neuroendocrine pathways provide several biologically plausible routes through which intestinal and skin health can interact. This does not mean that every case of rosacea originates in the gut.

What the SIBO research suggests

A frequently cited clinical study by Parodi and colleagues evaluated SIBO in patients with rosacea and reported improvement in rosacea after eradication of SIBO in affected participants. That finding is clinically interesting, but it should not be interpreted to mean that SIBO testing or antibiotic treatment is appropriate for every person with rosacea.

The higher-yield clue is the combination of skin disease with gastrointestinal symptoms such as persistent bloating, abdominal distention, altered bowel habits, excessive belching or other meal-related symptoms. In that setting, a clinician may consider whether a gastrointestinal evaluation—including breath testing in an appropriate patient—could add useful information.

A case-based example

One legacy Clinical Edge case involved a woman in her early forties with years of facial redness, swelling and inflammatory papules and pustules despite multiple skin-directed treatments. Her history also included bloating, irregular bowel habits, fatigue and food-related gastrointestinal symptoms. Breath testing was positive for SIBO.

Her care then broadened beyond the skin to address the identified gastrointestinal problem, dietary triggers, sleep, stress and overall gut health. Both her gastrointestinal symptoms and rosacea improved over the following months. A single case cannot prove causation, but it illustrates why a multisystem history can matter when a skin condition is difficult to control.

A Cellular Medicine approach to rosacea

• Treat the skin appropriately rather than withholding conventional dermatologic care.

• Look for gastrointestinal symptoms that make a gut evaluation clinically relevant.

• Consider diet and individual triggers without assuming every patient needs the same elimination diet.

• Evaluate medications, stress, sleep, metabolic health and environmental factors that may influence inflammatory signaling.

• Use antibiotics, herbal antimicrobials, probiotics or supplements selectively rather than as a universal rosacea protocol.

Functional dermatology is still dermatology

Looking upstream does not mean ignoring the skin. Rosacea can have multiple contributors, and patients still need an appropriate dermatologic assessment—particularly when the diagnosis is uncertain or when ocular symptoms, persistent lesions or other concerning findings are present. The goal is to integrate skin-directed care with a broader understanding of the patient's biology.

For selected patients, the gut–skin connection can be one useful piece of that picture. It is a reason to ask better questions, not a reason to assume that every case has the same root cause.

Reference: Parodi A, Paolino S, Greco A, et al. Small intestinal bacterial overgrowth in rosacea: clinical effectiveness of its eradication. Clinical Gastroenterology and Hepatology. 2008;6(7):759–764.

This article is educational and is not a substitute for individualized medical evaluation, diagnosis, or treatment.